INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

21,331 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
38
HL
Hoff LarryDirector
RVSBRIVERVIEW BANCORP INC
Open-market purchase
BUY$10K
1,920 sh
May 5, 2026May 7, 2026
Page 285 of 534
← PrevNext →
traded May 5, 2026
+2d
SEC Form 4

Evidence

36
NM
Norsa MicheleDirector
ZGNErmenegildo Zegna N.V.
Open-market sale
SELL$47K
4,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
DJ
Deegan Brian JohnGroup Chief Accounting Officer
HGHamilton Insurance Group, Ltd.
Open-market sale
SELL$338K
11.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
WL
Walsh Elizabeth L.Director
CARECarter Bankshares, Inc.
Open-market purchase
BUY$120K
4,575 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

36
GQ
Guo Jack Q.EVP & CFO
CSTMCONSTELLIUM SE
Open-market sale
SELL$822K
25.2K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
HJ
Holt Adrian JamesSVP, Chf HR Ofcr
EMNEASTMAN CHEMICAL CO
Open-market sale
SELL$132K
1,709 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
CL
Campbell Renee LSVP, Capital Markets & Risk
VMIVALMONT INDUSTRIES INC
Open-market sale
SELL$215K
412 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

30
CM
Chan MitchellDirector
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$72K
3,167 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

30
BL
Brown Claude LeonardChief Business Officer
PINSPINTEREST, INC.
Open-market sale
SELL$1.27M
61.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

29
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
19.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

29
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$953K
44.9K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

28
JC
Jaime CesarDirector
PTENPATTERSON UTI ENERGY INC
Open-market sale
SELL$123K
10.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

28
RF
Robin Jodi F.General Counsel and Secretary
TRSTRIMAS CORP
Open-market sale
SELL$123K
3,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
8,900 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

26
GP
Gallagher Thomas P.Director, Chairman & CEO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$756K
15.8K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

26
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$230K
10.1K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$496K
27.5K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$257K
13.8K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
NM
Neagle MatthewChief Operating Officer
PRCHPorch Group, Inc.
Open-market sale
SELL$634K
60.8K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

24
RF
Robin Jodi F.General Counsel and Secretary
TRSTRIMAS CORP
Open-market sale
SELL$83K
2,000 sh
May 7, 2026May 7, 2026
traded May 7, 2026
+0dSEC Form 4

Evidence

23
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$47K
15.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$111K
10.6K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

22
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$197K
9,219 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
12.3K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
CG
Canup Edward GCHIEF BANKING OFFICER
CBANCOLONY BANKCORP INC
Open-market purchase
BUY$20K
1,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

21
VJ
Viana Antonio JDirector
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$601K
20.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

19
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
1,679 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

18
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
5,000 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

18
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$56K
2,700 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

13
SJ
Sellers JeanetteSVP of Accounting
NCNOnCino, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
3,695 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

12
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Open-market sale · 10b5-1 plan
SELL$299K
16.6K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

10
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$174K
5,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

9
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$261K
8,333 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

9
BB
Borgeson BlakeDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$106K
30.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

9
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$145K
20.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

7
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$30K
9,722 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

7
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$30K
9,722 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

7
SH
Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$31K
9,722 sh
May 7, 2026May 7, 2026
traded May 7, 2026
+0dSEC Form 4

Evidence

6
BN
Baruch NiranChief Financial Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$16K
1,875 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

6
BN
Baruch NiranChief Financial Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$16K
1,875 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence